Frontiers in Immunology · 2018 · 79 citations · 22 references
Life SciencesClinical SciencesImmunologyAutoimmunityGene ExpressionRheumatologyAutoimmune BiomarkersAutoimmune DiseasesAutoimmune Rheumatic DiseasesRheumatoid ArthritisSystemic Autoimmune DiseaseSystemic Lupus ErythematosusCirculating MicrornasCirculating Rna BiomarkersDisease Activity MeasurementDisease-associated MicrornasMicrorna BiomarkersMicrorna Expression ProfilingMicrorna ScreeningSystemic Lupus Erythematosus Associations
Our understanding of circulating miRNAs related to systemic lupus erythematosus (SLE) remains very limited. In this study, we screened SLE-specific miRNAs in plasma from 42 B cell-related miRNAs by using miRNA PCR Array. The selected miRNAs were firstly confirmed in plasma samples from 50 SLE patients, 16 rheumatoid arthritis (RA) patients and 20 healthy donors using qRT-PCR. We then investigated the relationship between expressions of the selected miRNAs and SLE clinical indicators. As a result, fourteen miRNAs (miR-103, miR-150, miR-20a, miR-223, miR-27a, miR-15b, miR-16, miR-181a, miR-19b, miR-22, miR-23a, miR-25, miR-92a and miR-93) were significantly decreased in the plasma of SLE patients compared with healthy controls (P<0.05) and could act as the diagnostic signature to distinguish SLE patients from healthy donors. Six miRNAs (miR-92a, miR-27a, miR-19b, miR-23a, miR-223 and miR-16) expressed in plasma were significantly lower in SLE patients than in RA patients (P<0.05), revealing the potentially diagnostic signature to distinguish SLE patients from RA patients. Furthermore, the downregulated expression of miR-19b, miR-25, miR-93 and miR-15b was associated with SLE disease activity (P<0.05) while miR-15b and miR-22 expressions were significantly lower in SLE patients with low eGFR (eGFR<60 ml/min/1.73m2) (P<0.05).The diagnostic potential of miR-15b for SLE disease activity and lupus nephritis with low eGFR was validated on an independent validation set with 69 SLE patients and a cross-validation set with 80 SLE patients. In summary, the signature of circulating miRNAs will provide novel biomarkers for the diagnosis of SLE and evaluation of disease activity and lupus nephritis.
22
Daniel Aletaha, Tuhina Neogi, Alan J. Silman et al. · Arthritis & Rheumatism · 2010 · 9.6K citations · Full text
Medicine, Internal Medicine, Clinical Classification Systems +13
Konstantin D. Taganov, Mark Boldin, Kuang‐Jung Chang et al. · Proceedings of the National Academy of Sciences · 2006 · 4.3K citations · Full text
The MicroRNA Spectrum in 12 Body Fluids
Jessica A. Weber, David Baxter, Shile Zhang et al. · Clinical Chemistry · 2010 · 2.7K citations · Full text